Ru Zhou is a Principal Scientist at Pfizer, specializing in medicinal chemistry within the oncology research and development group. Educated with a Masters degree from Arizona State University, their work focuses on the discovery and synthesis of novel small molecule inhibitors, evidenced by multiple publications and patents.
Ru is credited as a co-inventor on several Pfizer patents for innovative compounds, including inhibitors of HPK1, designed for cancer treatment.
Read the full overview →Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.